^
    over1year
    Universal 4SCAR7U Targeting CD7-positive Malignancies (clinicaltrials.gov)
    P1, N=30, Recruiting, Shenzhen Geno-Immune Medical Institute
    New P1 trial
    |
    CD7 (CD7 Molecule)
    |
    4SCAR7U